Literature DB >> 19716161

Intestinal metaplasia in gallbladder correlates with high amylase levels in bile in patients with a morphologically normal pancreaticobiliary duct.

Hirotsugu Sakamoto1, Hiroyuki Mutoh, Kenichi Ido, Shin Satoh, Machio Kumagai, Hiroko Hayakawa, Kiichi Tamada, Kentaro Sugano.   

Abstract

We reported previously that intestinal metaplasia in the gallbladder is strongly associated with expression of caudal-related homeobox transcription factor Cdx2. It has been documented that occult pancreatobiliary reflux, even in the absence of pancreaticobiliary maljunction, is associated with elevated risk of biliary malignancy. We ascertained the correlation between intestinal metaplasia in the gallbladder and occult pancreatobiliary reflux. In 196 patients with a normal pancreaticobiliary ductal arrangement who had undergone laparoscopic cholecystectomy, we performed intraoperative cholangiography and measured amylase levels in bile sampled from the gallbladder. The cutoff value for high cystic amylase was defined as a biliary amylase level higher than the normal upper limit of serum amylase (215 IU/L). We also retrospectively reviewed the cholecystectomized tissue specimens to investigate the presence of intestinal metaplasia and expression of Cdx2. Then, we explored the relationship between intestinal metaplasia in the gallbladder and occult choledocho-pancreatic reflux. Intestinal metaplasia was found in 16.8% (33/196) of the gallbladders. The prevalence of choledocho-pancreatic reflux revealed by intraoperative cholangiography was not significantly different between cases with intestinal metaplasia (5/33, 15.2%) and those without (25/163, 15.3%; P = .81). However, in cases with intestinal metaplasia, the rate of high cystic amylase (13/33, 39.4%) was significantly higher compared with cases without intestinal metaplasia (26/163, 16.0%, P = .005). In conclusion, intestinal metaplasia in the gallbladder is significantly correlated with high amylase levels in bile in patients with a morphologically normal pancreaticobiliary ductal arrangement.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19716161     DOI: 10.1016/j.humpath.2009.06.008

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

Review 1.  Japanese clinical practice guidelines for pancreaticobiliary maljunction.

Authors:  Terumi Kamisawa; Hisami Ando; Masafumi Suyama; Mitsuo Shimada; Yuji Morine; Hiroshi Shimada
Journal:  J Gastroenterol       Date:  2012-06-22       Impact factor: 7.527

Review 2.  Pancreaticobiliary reflux in patients with a normal pancreaticobiliary junction: Pathologic implications.

Authors:  Marcelo A Beltrán
Journal:  World J Gastroenterol       Date:  2011-02-28       Impact factor: 5.742

3.  Pancreaticobiliary reflux as a high-risk factor for biliary malignancy: Clinical features and diagnostic advancements.

Authors:  Reiji Sugita
Journal:  World J Hepatol       Date:  2015-07-08

4.  Clinicopathologic Differences in Patients with Gallbladder Cancer According to the Presence of Anomalous Biliopancreatic Junction.

Authors:  Jihoon Chang; Jin-Young Jang; Mee Joo Kang; Woohyun Jung; Yong Chan Shin; Sun-Whe Kim
Journal:  World J Surg       Date:  2016-05       Impact factor: 3.352

5.  SOX9 Is Highly Expressed in Nonampullary Duodenal Adenoma and Adenocarcinoma in Humans.

Authors:  Hirotsugu Sakamoto; Hiroyuki Mutoh; Yoshimasa Miura; Miho Sashikawa; Hironori Yamamoto; Kentaro Sugano
Journal:  Gut Liver       Date:  2013-06-11       Impact factor: 4.519

6.  Common bile duct stones associated with pancreatobiliary reflux and disproportionate bile duct dilatation.

Authors:  Cheal Wung Huh; Hee Wook Kim; Seung Woo Yi; Dong Ki Lee; Se Joon Lee
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

7.  Colorectal metastasis to the gallbladder mimicking a primary gallbladder malignancy: histopathological and molecular characteristics.

Authors:  Tessa J J de Bitter; Ragna L A van der Linden; Shannon van Vliet; Fieke Weren; Daoud Sie; Bauke Ylstra; Hans C van der Linden; Nikki Knijn; Marjolijn J L Ligtenberg; Rachel S van der Post; Femke Simmer; Iris D Nagtegaal
Journal:  Histopathology       Date:  2019-07-18       Impact factor: 5.087

8.  Free fatty acids and triglyceride change in the gallbladder bile of gallstone patients with pancreaticobiliary reflux.

Authors:  Yukai Xiang; Xiangyu Kong; Cheng Zhang; Chuanqi He; Jingli Cai; Ruiqi Lu; Bosen Zhang; Liu Lu; Yulong Yang
Journal:  Lipids Health Dis       Date:  2021-08-31       Impact factor: 3.876

9.  Reflux-Associated Cholecystopathy: Analysis of 76 Gallbladders From Patients With Supra-Oddi Union of the Pancreatic Duct and Common Bile Duct (Pancreatobiliary Maljunction) Elucidates a Specific Diagnostic Pattern of Mucosal Hyperplasia as a Prelude to Carcinoma.

Authors:  Takashi Muraki; Bahar Memis; Michelle D Reid; Takeshi Uehara; Tetsuya Ito; Osamu Hasebe; Shinji Okaniwa; Naoto Horigome; Takeshi Hisa; Pardeep Mittal; Alexa Freedman; Shishir Maithel; Juan M Sarmiento; Alyssa Krasinskas; Jill Koshiol; Volkan Adsay
Journal:  Am J Surg Pathol       Date:  2017-09       Impact factor: 6.394

10.  Long-term follow-up may be needed for pancreaticobiliary reflux in healthy adults.

Authors:  Sung-Pil Yun; Jee Yeon Lee; Hong Jae Jo; Hyun Sung Kim; Dae Hwan Kim; Jae Hun Kim; Sung Jin Park; Do Yoon Park; Hyung-Il Seo
Journal:  J Korean Surg Soc       Date:  2013-01-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.